Keyphrases
Inflammatory Bowel Disease
100%
Humoral Immune Response
27%
Methotrexate
27%
SARS-CoV-2 Vaccination
26%
Severe Acute Respiratory Syndrome coronavirus-2 Vaccine
22%
Crohn's Disease
22%
Methotrexate Treatment
18%
Vedolizumab
18%
COVID-19
17%
5-fluorouracil (5-FU)
17%
Hamster
17%
Oral mucositis
17%
Ulcerative Colitis
16%
Anti-tumor Necrosis Factor (anti-TNF)
15%
Adverse Events
14%
Antibody Level
14%
Nitric Oxide
12%
Disease Activity
11%
Sperm DNA Integrity
11%
Sperm Quality
11%
Confidence Interval
10%
Ustekinumab
10%
Male Infertility
9%
Low-dose Methotrexate
9%
Sperm DNA
9%
Vaccination
9%
Personalized Medicine
8%
John Cunningham Virus
8%
Vaccine Development
8%
Male Pregnancy
8%
Maintenance Therapy
8%
Bowel Dysfunction
8%
Therapeutic Drug Monitoring
8%
Crohn's Colitis
8%
Immune-mediated Colitis
8%
Checkpoint Inhibitors
8%
Primary Sclerosing Cholangitis
8%
Disease Development
8%
Liver Biochemistry
8%
Peritoneal Perforation
8%
Clinical Trials
8%
Low Dose Rate
8%
Coronavirus Disease (COVID)
8%
Colitis
8%
Fertility Outcomes
8%
Real-world Outcomes
8%
Glutamine
8%
Concurrent Diagnoses
8%
Long-term Efficacy
8%
Very Early-onset Inflammatory Bowel Disease
8%
Medicine and Dentistry
Inflammatory Bowel Disease
78%
Patient with Inflammatory Bowel Disease
36%
COVID-19 Vaccination
35%
Severe Acute Respiratory Syndrome Coronavirus 2
30%
COVID-19
28%
Humoral Immunity
27%
Crohn's Disease
27%
Methotrexate
18%
Vedolizumab
18%
Infection
17%
Adverse Event
17%
Ulcerative Colitis
14%
Disease Activity
11%
Diseases
11%
Disease Course
10%
Patient with Crohn's Disease
10%
Ustekinumab
10%
Clinical Trial
10%
Male Fertility
9%
Low Drug Dose
9%
Eosinophilic Esophagitis
8%
Colitis
8%
Therapeutic Drug Monitoring
8%
Enteropathy
8%
Paternal Exposure
8%
Cohort Effect
8%
Personalized Medicine
8%
Pediatrics
8%
Maintenance Therapy
8%
Gut
8%
Tumor Necrosis
8%
Primary Sclerosing Cholangitis
8%
Surgical Approach
5%
Antibiotic Therapy
5%
Odds Ratio
5%
Antibody Response
5%
Hazard Ratio
5%
Receptor Binding
5%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
62%
Ulcerative Colitis
27%
Methotrexate
26%
Crohn's Disease
19%
Oral Mucositis
17%
Vedolizumab
17%
Fluorouracil
17%
Mucosa Inflammation
12%
Nitric Oxide
11%
Inducible Nitric Oxide Synthase
8%
Primary Sclerosing Cholangitis
8%
Paternal Exposure
8%
Clinical Trial
8%
SARS Coronavirus
8%
Therapeutic Drug Monitoring
8%
Glutamine
8%
Eosinophilic Esophagitis
8%
Enteropathy
8%
Tumor Necrosis
8%
Ustekinumab
8%
Tofacitinib
8%
Diseases
8%
Infection
7%
Myeloperoxidase
6%
Aminoguanidine
5%
Sex Hormone
5%